Genomic analysis identifies association of Fusobacterium with colorectal carcinoma AD Kostic, D Gevers, CS Pedamallu, M Michaud, F Duke, AM Earl, ... Genome research 22 (2), 292-298, 2012 | 2051 | 2012 |
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion R Straussman, T Morikawa, K Shee, M Barzily-Rokni, ZR Qian, J Du, ... Nature 487 (7408), 500-504, 2012 | 1962 | 2012 |
Long-term colorectal-cancer incidence and mortality after lower endoscopy R Nishihara, K Wu, P Lochhead, T Morikawa, X Liao, ZR Qian, K Inamura, ... New England Journal of Medicine 369 (12), 1095-1105, 2013 | 1609 | 2013 |
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ... The Journal of pathology 232 (2), 199-209, 2014 | 1497 | 2014 |
Serrated lesions of the colorectum: review and recommendations from an expert panel DK Rex, DJ Ahnen, JA Baron, KP Batts, CA Burke, RW Burt, JR Goldblum, ... The American journal of gastroenterology 107 (9), 1315-1329, 2012 | 1278 | 2012 |
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer S Bullman, CS Pedamallu, E Sicinska, TE Clancy, X Zhang, D Cai, ... Science 358 (6369), 1443-1448, 2017 | 1191 | 2017 |
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival X Liao, P Lochhead, R Nishihara, T Morikawa, A Kuchiba, M Yamauchi, ... New England Journal of Medicine 367 (17), 1596-1606, 2012 | 1038 | 2012 |
Cancer classification using the Immunoscore: a worldwide task force | 957* | 2012 |
Genomic correlates of immune-cell infiltrates in colorectal carcinoma M Giannakis, XJ Mu, SA Shukla, ZR Qian, O Cohen, R Nishihara, S Bahl, ... Cell reports 15 (4), 857-865, 2016 | 942 | 2016 |
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 AT Chan, S Ogino, CS Fuchs New England Journal of Medicine 356 (21), 2131-2142, 2007 | 925 | 2007 |
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer S Ogino, K Nosho, GJ Kirkner, T Kawasaki, JA Meyerhardt, M Loda, ... Gut 58 (1), 90-96, 2009 | 906 | 2009 |
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis K Mima, R Nishihara, ZR Qian, Y Cao, Y Sukawa, JA Nowak, J Yang, ... Gut 65 (12), 1973-1980, 2016 | 897 | 2016 |
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity AM Dulak, P Stojanov, S Peng, MS Lawrence, C Fox, C Stewart, S Bandla, ... Nature genetics 45 (5), 478-486, 2013 | 861 | 2013 |
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity R Firestein, AJ Bass, SY Kim, IF Dunn, SJ Silver, I Guney, E Freed, ... Nature 455 (7212), 547-551, 2008 | 802 | 2008 |
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth R Firestein, G Blander, S Michan, P Oberdoerffer, S Ogino, J Campbell, ... PloS one 3 (4), e2020, 2008 | 734 | 2008 |
Aspirin use and survival after diagnosis of colorectal cancer AT Chan, S Ogino, CS Fuchs Jama 302 (6), 649-658, 2009 | 671 | 2009 |
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development JR Mayers, C Wu, CB Clish, P Kraft, ME Torrence, BP Fiske, C Yuan, ... Nature medicine 20 (10), 1193-1198, 2014 | 650 | 2014 |
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum M Yamauchi, T Morikawa, A Kuchiba, Y Imamura, ZR Qian, R Nishihara, ... Gut 61 (6), 847-854, 2012 | 640 | 2012 |
Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review K Nosho, Y Baba, N Tanaka, K Shima, M Hayashi, JA Meyerhardt, ... The Journal of pathology 222 (4), 350-366, 2010 | 588 | 2010 |
Molecular classification and correlates in colorectal cancer S Ogino, A Goel The Journal of Molecular Diagnostics 10 (1), 13-27, 2008 | 583 | 2008 |